American Oncology Network Announces Voluntary Delisting From Nasdaq
FORT MYERS, Fla., May 21, 2024 (GLOBE NEWSWIRE) — American Oncology Network (“AON” or the “Company”) (Nasdaq:AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market (“Nasdaq”). The Company’s decision to delist its securities from Nasdaq was recommended to the Board of Directors (the “Board”) of the Company by a Special Committee (the “Special Committee”) of the Board comprised solely of independent directors.
Related news for (AONC)
- Indianapolis Medical Oncologist Co-authors Research Presented at International Lymphoma Symposium
- American Oncology Network Announces the Commencement of OTCQX Trading
- American Oncology Network Expands Radiation Oncology Services, Opens New Clinic
- American Oncology Network Announces the Research Studies Presented at the ASCO 2024 Annual Meeting
- American Oncology Network Appoints David Afshar as Chief Financial and Operating Officer